CHABELINA FE (ndac and ee tablets and ferrous fumarate tablets) by Novast Labs is clinical pharmacology oral contraception combination oral contraceptives act by suppression of gonadotropins. Approved for pregnancy in women, moderate acne vulgaris in females, ≥15 years of age and 5 more indications. First approved in 2020.
Drug data last refreshed 13h ago
CLINICAL PHARMACOLOGY ORAL CONTRACEPTION Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increase the difficulty of sperm entry into the…
Worked on CHABELINA FE at Novast Labs? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.